{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T20:11:54Z","timestamp":1651263114693},"reference-count":14,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5761\/atcs.oa.14-00262","type":"journal-article","created":{"date-parts":[[2015,2,15]],"date-time":"2015-02-15T22:01:56Z","timestamp":1424037716000},"page":"345-353","source":"Crossref","is-referenced-by-count":2,"title":["Significant Prognostic Factors for Completely Resected pN2 Non-small Cell Lung Cancer without Neoadjuvant Therapy"],"prefix":"10.5761","volume":"21","author":[{"given":"Hirofumi","family":"Uehara","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyon","family":"Mun","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakae","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: e314S-40S.","DOI":"10.1378\/chest.12-2360"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 1996; 14: 1048-54.","DOI":"10.1200\/JCO.1996.14.4.1048"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tada H, Tsuchiya R, Ichinose Y, et al. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 2004; 43: 167-73.","DOI":"10.1016\/j.lungcan.2003.08.028"},{"key":"4","unstructured":"4) Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. Cochrane Database Syst Rev 2010; 12: CD007309."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004; 64: 8919-23.","DOI":"10.1158\/0008-5472.CAN-04-2818"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sonobe M, Kobayashi M, Ishikawa M, et al. Impact of KRAS and EGFR gene mutations on recurrence and survival in patients with surgically resected lung adenocarcinomas. Ann Surg Oncol 2012; 19: 347-54.","DOI":"10.1245\/s10434-011-1799-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L (2007) The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumors. J Throac Oncol 2: 706-714.","DOI":"10.1097\/JTO.0b013e31812f3c1a"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sonobe M, Date H, Wada H, et al. Prognostic factors after complete resection of pN2 non-small cell lung cancer. J Thorac Cardiovasc Surg 2013; 146: 788-95.","DOI":"10.1016\/j.jtcvs.2013.04.043"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Morgensztern D, Waqar S, Subramanian J, et al. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005. J Thorac Oncol 2009; 4: 1524-1529.","DOI":"10.1097\/JTO.0b013e3181ba3634"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nakagiri T, Sawabata N, Funaki S, et al. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2011; 12: 733-8.","DOI":"10.1510\/icvts.2010.249896"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Maximus S, Nguyen DV, Mu Y, et al. Size of Stage IIIA primary lung cancers and survival: a surveillance, epidemiology and end results database analysis. Am Surg 2012; 78: 1232-7.","DOI":"10.1177\/000313481207801131"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Riquet M, Assouad J, Bagan P, et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 2005; 79: 225-33.","DOI":"10.1016\/j.athoracsur.2004.06.081"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Misthos P, Sepsas E, Kokotsakis J, et al. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg 2008; 86: 1626-30.","DOI":"10.1016\/j.athoracsur.2008.07.076"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Uehara H, Sakao Y, Mun M, et al. Prognostic value and significance of subcarinal and superior mediastinal lymph node metastasis in lower lobe tumours. Eur J Cardiothorac Surg 2010; 38: 498-502.","DOI":"10.1016\/j.ejcts.2010.02.027"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/21\/4\/21_oa.14-00262\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T19:29:41Z","timestamp":1651260581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/21\/4\/21_oa.14-00262\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.14-00262","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}